Furthermore, HER2, EGFRvIII, and IL-13 receptor α 2 (IL-13 Rα2) are also exposed on the surface of cancer stem cells (CSCs), paving the way for new possible application of CAR-T therapy in cancer immunology [82]. The gene discussed is ERBB2; the disease is cancer.